19 completed, 8 terminated, 2 unknown, 1 recruiting. 16 Phase 4, 4 Not applicable, 3 Phase 1, 3 Phase 2, 1 Early Phase 1.
Follow Iopamidol: new trials by email Literature Review of Iopamidol trials Research Report on Iopamidol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy Bupivacaine, Hydromorphone, Iopamidol - Duodenal Neoplasm, Pancreatic Neoplasm | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 78 | 2023-11-10 | 2026-02-03 |
| Serum Thyroid Function After Iodinated Contrast Administration Iodinated contrast agents - Thyroid Dysfunction | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 400 | 2023-02-15 | 2023-05-30 | |
| Effects of Contrast Media Temperature on Image Quality and Clinical Adverse Events in Coronary CTA Iopamidol - Contrast Media Adverse Reaction | Not applicable | Unknown | Chongqing Emergency Medical Center | 500 | 2022-02-01 | 2022-08-05 |
| PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease Coronary computed tomography angiography (CCTA), Isovue, Nitroglycerin - Non-Obstructive Coronary Atherosclerosis | Terminated | NYU Langone Health | 32 | 2021-07-12 | 2025-04-29 | |
| Study With Oral Isovue in Abdominopelvic CT Iopamidol - Patients Requiring Abdominopelvic CT With Oral Administration of Contrast | Completed | Bracco Diagnostics, Inc | 218 | 2021-07-01 | 2023-02-08 | |
| Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis Advanced Magnetic Resonance Imaging, Conventional Magnetic Resonance Imaging, Gadolinium-Chelate - Malignant Solid Neoplasm | Not applicable | Completed | M.D. Anderson Cancer Center | 15 | 2021-03-30 | 2024-11-06 |
| Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer Infigratinib, Tamoxifen, Omnipaque 350 - Breast Cancer, HER2-negative Breast Cancer | Phase 1 | Terminated | Jennifer Lee Caswell-Jin | 4 | 2020-10-13 | 2026-02-12 |
| Thyroid Function of Pediatric Subjects Following Isovue® Administration Isovue - Hypothyroidism | Phase 4 | Terminated | Bracco Diagnostics, Inc | 17 | 2019-03-26 | 2025-07-30 |
| Adenosine Contrast CorrELations in Evaluating RevAscularizaTION Iopamidol, adenosine, Navvus® Catheter - Percutaneous Coronary Intervention | Phase 4 | Completed | Duke University | 201 | 2019-01-17 | 2024-07-05 |
| Optimization of Contrast Agent Dose in CT With Lean Body Weight Iopamidol - Contrast Agent With Lean Body Weight | Phase 4 | Completed | IRCCS Policlinico S. Donato | 274 | 2017-12-18 | 2019-05-06 |
| CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy CAPP-Seq, Isovue-200, Computed Tomography Perfusion Imaging - Malignant Lung Neoplasm, Metastatic Malignant Neoplasm in the Lung | Phase 1 | Completed | Stanford University | 19 | 2016-01-19 | 2023-11-22 |
| Customized Contrast Media Dose Clinical Trial Iopamidol, Mydose - CT of the Abdomen and Pelvis With Contrast Material | Not applicable | Terminated | Duke University | 166 | 2015-08-01 | 2020-06-16 |
| An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer CEST MRI - Breast Cancer | Early Phase 1 | Terminated | University of Arizona | 8 | 2014-08-01 | 2016-10-27 |
| Thoracoabdominal Arortic CTA Study Isovue - Thoracic Aortic Aneurysm | Phase 4 | Completed | Duke University | 150 | 2014-01-01 | 2017-04-18 |
| Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers Ioforminol 160 mgI/mL, Ioforminol 200 mgI/mL, Iopamidol 300 mgI/mL - Healthy | Phase 1 / Phase 2 | Completed | GE Healthcare | 66 | 2012-07-01 | 2014-05-29 |
| Low-dose Laxative Improves Performance and Feasibility of Computed Tomography Colonography (CTC) Bisacodyl & PEG-CS, Iopamidol - Gastrointestinal Complication | Phase 4 | Completed | Azienda Policlinico Umberto I | 52 | 2012-02-01 | 2014-01-20 |
| Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography Iodixanol, Iopamidol - Drug Safety | Phase 4 | Completed | GE Healthcare | 255 | 2011-10-01 | 2014-06-11 |
| Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis Iodixanol, Iopamidol - Patient Comfort and Safety | Phase 4 | Completed | GE Healthcare | 304 | 2011-05-01 | 2013-12-19 |
| Kidney Damage in Patients With Normal eGFR Non ionic contrast media comparator - Coronary Artery Stenosis | Phase 4 | Completed | Bracco Diagnostics, Inc | 49 | 2010-12-01 | 2013-09-30 |
| Kidney Damage in Patients With Moderate Fall in eGFR Iopamidol, Iodixanol-320 - Coronary Artery Stenosis | Phase 4 | Completed | Bracco Diagnostics, Inc | 57 | 2010-11-01 | 2020-11-04 |
Showing 20 of 30. Sign in to see all of them.
Coronary Stenosis (3) · Breast Neoplasms (2) · Coronary Artery Disease (2) · Diabetes Mellitus (2) · Peripheral Arterial Occlusive Disease 1 (2) · Aortic Aneurysm, Thoracic (1) · Aortic Aneurysm, Thoracoabdominal (1) · Carcinoma, Non-Small-Cell Lung (1) · Duodenal Neoplasms (1) · Hypothyroidism (1) · Lung Neoplasms (1) · Pancreatic Neoplasms (1) · Pulmonary Embolism (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Bracco Diagnostics, Inc (10) · Duke University (5) · GE Healthcare (4) · Azienda Policlinico Umberto I (1) · Chongqing Emergency Medical Center (1) · IRCCS Policlinico S. Donato (1) · Jennifer Lee Caswell-Jin (1) · M.D. Anderson Cancer Center (1) · Masonic Cancer Center, University of Minnesota (1) · Massachusetts General Hospital (1) · NYU Langone Health (1) · Stanford University (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · University of Arizona (1)
United States (22) · Canada (2) · China (2) · Italy (2) · United Kingdom (1)
Lauren Lim, PharmD (2) · Maria Luigia Storto, MD (2) · Alberto Spinazzi, M.D. (1) · Brian B Ghoshhajra, MD (1) · Daniel T Boll, MD (1) · Daniele Marin, MD (1) · James Flaherty (1) · Jason M Johnson (1) · Jennifer Lee Caswell-Jin (1) · Jiefen Yao, M.D. (1) · Judith A Johnson, MS, MBA (1) · Li Yan (1) · Lisa Ho, MD (1) · Martin Krix, M.D. (1) · Mary Luigia Storto, MD (1)
PMID 19744616, PMID 19936863, PMID 20093513, PMID 22146505, PMID 22210535, PMID 22222164, PMID 34280944, PMID 40270240, PMID 41521999
K08CA252457 (1), P30CA077598 (1)